An example of toxic medicine used in Traditional Chinese Medicine for cancer treatment.
作者信息
Hengrui Liu
机构信息
Tianjin Yinuo Biomedical Co., Ltd., Tianjin 061102, China.
出版信息
J Tradit Chin Med. 2023 Apr;43(2):209-210. doi: 10.19852/j.cnki.jtcm.2023.02.001.
Abstract
摘要
相似文献
1
An example of toxic medicine used in Traditional Chinese Medicine for cancer treatment.
J Tradit Chin Med. 2023 Apr;43(2):209-210. doi: 10.19852/j.cnki.jtcm.2023.02.001.
2
[Clinical research of traditional Chinese medicine in treatment of toxic and adverse reactions of radiotherapy for malignant tumor: current status].
Zhong Xi Yi Jie He Xue Bao. 2007 Jul;5(4):470-4. doi: 10.3736/jcim20070423.
3
Rethinking traditional Chinese medicines for cancer.
Lancet Oncol. 2015 Nov;16(15):1439. doi: 10.1016/S1470-2045(15)00406-4.
4
Synergy in traditional Chinese medicine.
Lancet Oncol. 2016 Feb;17(2):e39. doi: 10.1016/S1470-2045(15)00557-4.
5
[Effect and expectation of traditional Chinese medicine on prevention and treatment of tumor].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 May;27(5):389-90.
6
[Application of traditional Chinese patent drugs in cancer treatment].
Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):400.
7
[Application of traditional Chinese medicine in interventional treatment of carcinoma].
Zhong Xi Yi Jie He Xue Bao. 2003 Sep;1(3):230-3. doi: 10.3736/jcim20030326.
8
[Effect and status of traditional Chinese medicine on tumor].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 May;27(5):390-1.
9
A new dawn for the use of traditional Chinese medicine in cancer therapy.
Mol Cancer. 2009 Mar 20;8:21. doi: 10.1186/1476-4598-8-21.
10
Anti-tumor effects of traditional Chinese medicine give a promising perspective.
J Cancer Res Ther. 2014 Aug;10 Suppl 1:1-2. doi: 10.4103/0973-1482.139741.
引用本文的文献
1
Role of traditional Chinese medicine in supporting liver transplantation outcomes.
World J Transplant. 2025 Sep 18;15(3):103904. doi: 10.5500/wjt.v15.i3.103904.
2
Targeting GABA signaling in the tumor microenvironment: implications for immune cell regulation and immunotherapy resistance.
Front Immunol. 2025 Aug 5;16:1645718. doi: 10.3389/fimmu.2025.1645718. eCollection 2025.
3
Evaluating the scope and impact of pre-diagnostic manipulative therapy in children and adolescents with osteosarcoma: A retrospective study in Uganda.
PLoS One. 2025 Aug 4;20(8):e0329688. doi: 10.1371/journal.pone.0329688. eCollection 2025.
4
The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637.
Hereditas. 2025 Jul 26;162(1):144. doi: 10.1186/s41065-025-00511-7.
5
Harnessing traditional medicine and biomarker-driven approaches to counteract Trichostatin A-induced esophageal cancer progression.
World J Gastroenterol. 2025 May 28;31(20):106443. doi: 10.3748/wjg.v31.i20.106443.
6
Efficacy and safety of paclitaxel combined with oxaliplatin in the treatment of advanced primary hepatocellular carcinoma.
Am J Cancer Res. 2025 Mar 15;15(3):1122-1132. doi: 10.62347/ZKIG9938. eCollection 2025.
7
SCN3B is an Anti-breast Cancer Molecule with Migration Inhibition Effect.
Biochem Genet. 2025 Mar 12. doi: 10.1007/s10528-025-11059-6.
8
Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers.
PLoS One. 2025 Jan 16;20(1):e0314745. doi: 10.1371/journal.pone.0314745. eCollection 2025.
9
Technical and Biological Biases in Bulk Transcriptomic Data Mining for Cancer Research.
J Cancer. 2025 Jan 1;16(1):34-43. doi: 10.7150/jca.100922. eCollection 2025.
10
Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study.
Chin Med. 2024 Oct 9;19(1):141. doi: 10.1186/s13020-024-01018-5.
本文引用的文献
1
Toxic medicine used in Traditional Chinese Medicine for cancer treatment: are ion channels involved?
J Tradit Chin Med. 2022 Dec;42(6):1019-1022. doi: 10.19852/j.cnki.jtcm.20220815.005.
2
Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
Front Oncol. 2022 Oct 6;12:952290. doi: 10.3389/fonc.2022.952290. eCollection 2022.
3
A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic Prediction.
Front Oncol. 2022 Mar 10;12:858756. doi: 10.3389/fonc.2022.858756. eCollection 2022.
4
A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma.
Gene. 2022 May 15;822:146325. doi: 10.1016/j.gene.2022.146325. Epub 2022 Feb 17.
5
Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma.
Cancer Biomark. 2022;34(3):359-374. doi: 10.3233/CBM-210340.
Zotero 插件